TREŚĆ SPONSOROWANA

Profil pacjenta - kobieta w ciąży chorująca na stwardnienie rozsiane

Zapisuję

Zapisz

Zapisane

Autor: Biogen

27.01.2023

Partner publikacji

Opis przypadku

Do neurologa skierowana została 28-letnia pacjentka będąca w 26. tygodniu ciąży., celem pozyskania informacji dotyczących możliwości leczenia stwardnienia rozsianego w trakcie ciąży. U pacjentki przed tygodniem postawiono rozpoznanie stwardnienia rozsianego (SM) - postać RRMS (rzutowo-remisyjna).

badanie

leki

Źródła

Pugliatti M, Sotgiu S and Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002; 104: 182–191.
Alwan S, Yee IM, Dybalski M, et al. Reproductive decision making after the diagnosis of multiple sclerosis (MS). Mult) Scler. 2013;19(3):351-358.
Wundes A, Pebdani RN, Amtmann D. What do healthcare providers advise women with multiple sclerosis regarding pregnancy? Mult Scler Int 2014;2014:819216.
Mendibe Bilbao, M.; Boyero Durán, S.; Bárcena Llona, J.; Rodriguez-Antigüedad, A. Multiple sclerosis: Pregnancy and women’s health issues. Neurologia Engl. Ed. 2019, 34, 259–269.
Coyle, P.K. Management of women with multiple sclerosis through pregnancy and after childbirth. Ther. Adv. Neurol. Disord. 2016, 9, 198–210. [CrossRef]Coyle, P.K. Management of women with multiple sclerosis through pregnancy and after childbirth. Ther. Adv. Neurol. Disord. 2016, 9, 198–210. [CrossRef]
Varytė, G., Arlauskienė, A., & Ramašauskaitė, D. (2021). Pregnancy and multiple sclerosis: an update. Current opinion in obstetrics & gynecology, 33(5), 378–383. https://doi.org/10.1097/GCO.0000000000000731
Coyle, P.K.; Oh, J.; Magyari, M.; Oreja-Guevara, C.; Houtchens, M. Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review. Mult. Scler. Relat. Disord. 2019, 32, 54–63
Salminen, H.J., H. Leggett, and M. Boggild, Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol 257 (2010) 2020-3.
Voskuhl, R. and C. Momtazee, Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding. Neurotherapeutics 14 (2017) 974-984.
Varytė, G., Zakarevičienė, J., Ramašauskaitė, D., Laužikienė, D., & Arlauskienė, A. (2020). Pregnancy and Multiple Sclerosis: An Update on the Disease Modifying Treatment Strategy and a Review of Pregnancies Impact on Disease Activity. Medicina (Kaunas, Lithuania), 56(2), 49. https://doi.org/10.3390/medicina56020049
https://analizy.mz.gov.pl/html/sm_ciaza/ (ostatni dostęp: 12.11.2022 r.)
Siroos, B. and M.H. Harirchian, Multiple sclerosis and pregnancy; What a neurologist may be asked for? Iran J Neurol 13 (2014) 57-63.
Gold, S.M. and R.R. Voskuhl, Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application. Semin Immunopathol 38 (2016) 709-718.
Kelly VM, Nelson LM, Chakravarty EF.Obstetric outcomes in women with multiple sclerosis and epilepsy. Neurology 2009; 73(22): 1831-6.
Chen YH, Lin HL, Lin HC. Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study. Mult Scler 2009; 15(5): 606-12.
Langer-Gould A, Gupta R, Huang S, et al. Interferon-gamma-producing t cells, pregnancy, and postpartum relapses of multiple sclerosis. Arch Neurol. 2010; 67:51–57.
SIL Avonex